Literature DB >> 12235116

Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation.

Brendan A Hilliard1, Nicola Mason, Lingyun Xu, Jing Sun, Salah-Eddine Lamhamedi-Cherradi, Hsiou-Chi Liou, Christopher Hunter, Youhai H Chen.   

Abstract

Different members of the Rel/NF-kappaB family may play different roles in immunity and inflammation. We report here that c-Rel-deficient mice are resistant to autoimmune encephalomyelitis and are defective in Th1, but not Th2 responses. The Th1 deficiency appears to be caused by selective blockade of IL-12 production by c-Rel-deficient antigen-presenting cells, as well as by a complete abrogation of IFN-gamma expression in c-Rel-deficient T cells. Interestingly, c-Rel deficiency does not affect T-bet expression, suggesting that c-Rel may act downstream of T-bet during Th1 cell differentiation. Thus, unlike NF-kappaB1, which selectively regulates Th2 cell differentiation, c-Rel is essential for Th1 cell differentiation and Th1 cell-mediated autoimmune inflammation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12235116      PMCID: PMC151124          DOI: 10.1172/JCI15254

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  A novel transcription factor, T-bet, directs Th1 lineage commitment.

Authors:  S J Szabo; S T Kim; G L Costa; X Zhang; C G Fathman; L H Glimcher
Journal:  Cell       Date:  2000-03-17       Impact factor: 41.582

2.  Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis.

Authors:  R J Grumont; I J Rourke; S Gerondakis
Journal:  Genes Dev       Date:  1999-02-15       Impact factor: 11.361

3.  B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy.

Authors:  V K Kuchroo; M P Das; J A Brown; A M Ranger; S S Zamvil; R A Sobel; H L Weiner; N Nabavi; L H Glimcher
Journal:  Cell       Date:  1995-03-10       Impact factor: 41.582

Review 4.  The expanding universe of T-cell subsets: Th1, Th2 and more.

Authors:  T R Mosmann; S Sad
Journal:  Immunol Today       Date:  1996-03

5.  Transcription factor NF-kappa B is activated in microglia during experimental autoimmune encephalomyelitis.

Authors:  C Kaltschmidt; B Kaltschmidt; J Lannes-Vieira; G W Kreutzberg; H Wekerle; P A Baeuerle; J Gehrmann
Journal:  J Neuroimmunol       Date:  1994-11       Impact factor: 3.478

6.  Constitutive NF-kappa B activity in neurons.

Authors:  C Kaltschmidt; B Kaltschmidt; H Neumann; H Wekerle; P A Baeuerle
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

7.  Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor.

Authors:  S Gerondakis; A Strasser; D Metcalf; G Grigoriadis; J Y Scheerlinck; R J Grumont
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

8.  Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses.

Authors:  W C Sha; H C Liou; E I Tuomanen; D Baltimore
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

9.  Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family.

Authors:  F Weih; D Carrasco; S K Durham; D S Barton; C A Rizzo; R P Ryseck; S A Lira; R Bravo
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

10.  Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B.

Authors:  A A Beg; W C Sha; R T Bronson; S Ghosh; D Baltimore
Journal:  Nature       Date:  1995-07-13       Impact factor: 49.962

View more
  87 in total

1.  Loss of c-REL but not NF-κB2 prevents autoimmune disease driven by FasL mutation.

Authors:  L A O'Reilly; P Hughes; A Lin; P Waring; U Siebenlist; R Jain; D H D Gray; S Gerondakis; A Strasser
Journal:  Cell Death Differ       Date:  2014-10-31       Impact factor: 15.828

2.  c-Rel delivers a one-two punch in Th1 cell differentiation.

Authors:  Sung-Yun Pai; I-Cheng Ho
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

Review 3.  Peli: a family of signal-responsive E3 ubiquitin ligases mediating TLR signaling and T-cell tolerance.

Authors:  Wei Jin; Mikyoung Chang; Shao-Cong Sun
Journal:  Cell Mol Immunol       Date:  2012-02-06       Impact factor: 11.530

4.  The pathogenic Th17 cell response to major schistosome egg antigen is sequentially dependent on IL-23 and IL-1β.

Authors:  Mara G Shainheit; Krzysztof W Lasocki; Eduardo Finger; Bridget M Larkin; Patrick M Smith; Arlene H Sharpe; Charles A Dinarello; Laura I Rutitzky; Miguel J Stadecker
Journal:  J Immunol       Date:  2011-10-14       Impact factor: 5.422

Review 5.  Immunological synapse: a multi-protein signalling cellular apparatus for controlling gene expression.

Authors:  Kartika Padhan; Rajat Varma
Journal:  Immunology       Date:  2010-03       Impact factor: 7.397

6.  Role of the NF-κB transcription factor c-Rel in the generation of CD8+ T-cell responses to Toxoplasma gondii.

Authors:  Kimberly A Jordan; Christopher D Dupont; Elia D Tait; Hsiou-Chi Liou; Christopher A Hunter
Journal:  Int Immunol       Date:  2010-11       Impact factor: 4.823

7.  Modular utilization of distal cis-regulatory elements controls Ifng gene expression in T cells activated by distinct stimuli.

Authors:  Anand Balasubramani; Yoichiro Shibata; Gregory E Crawford; Albert S Baldwin; Robin D Hatton; Casey T Weaver
Journal:  Immunity       Date:  2010-07-23       Impact factor: 31.745

8.  Single-Cell Genomics Unveils Critical Regulators of Th17 Cell Pathogenicity.

Authors:  Jellert T Gaublomme; Nir Yosef; Youjin Lee; Rona S Gertner; Li V Yang; Chuan Wu; Pier Paolo Pandolfi; Tak Mak; Rahul Satija; Alex K Shalek; Vijay K Kuchroo; Hongkun Park; Aviv Regev
Journal:  Cell       Date:  2015-11-19       Impact factor: 41.582

Review 9.  NOD2 regulation of Toll-like receptor responses and the pathogenesis of Crohn's disease.

Authors:  T Watanabe; A Kitani; W Strober
Journal:  Gut       Date:  2005-11       Impact factor: 23.059

10.  A small-molecule c-Rel inhibitor reduces alloactivation of T cells without compromising antitumor activity.

Authors:  Yusuke Shono; Andrea Z Tuckett; Samedy Ouk; Hsiou-Chi Liou; Grégoire Altan-Bonnet; Jennifer J Tsai; Jennifer E Oyler; Odette M Smith; Mallory L West; Natalie V Singer; Ekaterina Doubrovina; Dmitry Pankov; Chandresh V Undhad; George F Murphy; Cecilia Lezcano; Chen Liu; Richard J O'Reilly; Marcel R M van den Brink; Johannes L Zakrzewski
Journal:  Cancer Discov       Date:  2014-02-18       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.